MON -

NYSE American . Currency in USD
Stock chart is not supported by your current browser
Previous CloseN/A
OpenN/A
BidN/A x N/A
AskN/A x N/A
Day's RangeN/A - N/A
52 Week Range0.09 - 0.09
VolumeN/A
Avg. Volume0
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Exclusive: Bayer's Monsanto wins arbitration ruling over royalties from Indian seed company
    Reuters5 days ago

    Exclusive: Bayer's Monsanto wins arbitration ruling over royalties from Indian seed company

    The lawyers, who did not wish to be named as the decision was not public, did not disclose the terms of the arbitration ruling. Mahyco Monsanto Biotech (India) (MMB), a joint venture between Missouri-based Monsanto and India's Maharashtra Hybrid Seeds Co (Mahyco), "has received a favorable award from the arbitration panel in the proceedings against NSL and Prabhat", a Bayer spokesman said in an e-mailed statement when asked about the ruling.

  • Return of French farmer's case keeps Monsanto in legal spotlight
    Reuters11 days ago

    Return of French farmer's case keeps Monsanto in legal spotlight

    Paul Francois, who says he fell ill after inhaling vapor from weedkiller Lasso in 2004, won rulings in 2012 and 2015 that found Monsanto liable for the intoxication, before France's top court overturned those decisions and ordered a new hearing. An appeal court in the southeastern French city of Lyon will hear arguments on Wednesday before giving its verdict at a later date. Francois, who says he has suffered memory loss, headaches and stammering, blames Monsanto for not giving sufficient warnings on the product label.

  • Monsanto patent victory seen as a boost for biotech investment in India
    Reuterslast month

    Monsanto patent victory seen as a boost for biotech investment in India

    NEW DELHI/MUMBAI (Reuters) - India's Supreme Court ruled on Tuesday that Monsanto can claim patents on its genetically modified (GM) cotton seeds, a victory for the U.S. company that is expected to encourage biotechnology firms to step up investment in the country. The decision on appeal overturns an earlier ruling by the Delhi High Court that Monsanto - the world's biggest seed maker, which has been bought by Germany's Bayer AG - could not claim patents on GM cotton seeds.

  • Business Wirelast month

    SolomonEdwards D.C. Practice Expands With New Experts

    SolomonEdwards, a national professional services firm, has added Kimberly Rodichok to its consulting team as a Director in their Technical Accounting and Regulatory Advisory Services Practice. As Director, Kimberly joins Brian McAuliffe, both of whom will support Greater Washington D.C. metro businesses in the areas of business transformation and project management. Kimberly, a seasoned management consultant with an accomplished history of providing counsel to federal clients, has a proven track record of effectively overseeing teams and elaborate projects.

  • Monsanto appeals $78M verdict in California weed killer suit
    The Canadian Press3 months ago

    Monsanto appeals $78M verdict in California weed killer suit

    Agribusiness giant Monsanto on Tuesday appealed a $78 million verdict in favour of a dying California man who said the company's widely used Roundup weed killer was a major factor in his cancer. The company filed a notice of appeal in San Francisco Superior Court challenging a jury verdict in favour of DeWayne Johnson. Monsanto had sought a new trial or judgment in its favour .

  • Judge upholds Monsanto weed killer cancer verdict but slashes damages to groundsman
    The Telegraph4 months ago

    Judge upholds Monsanto weed killer cancer verdict but slashes damages to groundsman

    A San Francisco judge on Monday upheld a jury verdict that found Monsanto liable for not warning a groundskeeper that its weed killer Roundup might cause cancer, but slashed the damages award.

  • Monsanto trial: judge rejects bid to overturn landmark cancer verdict
    The Guardian4 months ago

    Monsanto trial: judge rejects bid to overturn landmark cancer verdict

    Dewayne ‘Lee’ Johnson reacts after hearing the verdict in his case against Monsanto. A California judge has rejected Monsanto’s appeal to overturn a landmark jury verdict which found that its popular herbicide causes cancer. The judge’s ruling on Monday largely sided with Dewayne “Lee” Johnson, a father of three and former school groundskeeper, who won a $289m award over the summer after alleging that his exposure to Roundup weedkiller gave him cancer.

  • Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm
    Reuters4 months ago

    Brazil court denies Monsanto bid to halt seed licensing to bankrupt firm

    SAO PAULO (Reuters) - A Brazilian appeals court denied a request this month by Monsanto's local unit to suspend licensing of its popular Intacta soy seed technology to privately owned seed maker Sementes Talismã, according to a ruling seen by Reuters.

  • Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict
    Reuters5 months ago

    Bayer's Monsanto asks U.S. court to toss $289 mln glyphosate verdict

    The company said in motions filed in San Francisco's Superior Court of California that the jury's decision was insufficiently supported by the evidence presented at trial by school groundskeeper Dewayne Johnson. Johnson's case, filed in 2016, was fast-tracked for trial due to the severity of his non-Hodgkin's lymphoma, a cancer of the lymph system, that he alleged was caused by years of exposure to Roundup and Ranger Pro, another Monsanto herbicide that contains glyphosate. Monsanto asked Superior Court Judge Suzanne Bolanos, who oversaw the trial, to set aside the verdict or, in the alternative, reduce the award or grant a new trial.

  • Bayer cuts forecasts on Monsanto delay as lawsuits pile up
    Reuters5 months ago

    Bayer cuts forecasts on Monsanto delay as lawsuits pile up

    The weaker earnings forecast adds to a number of challenges facing the German drugmaker as it braces for years of legal wrangling over the alleged cancer risks of glyphosate-based weedkillers. Bayer said the number of plaintiffs seeking damages over Monsanto's Roundup and Ranger Pro herbicides had risen to 8,700 from 8,000 from last month, and said that it expected more to sue. The company lowered its forecast for adjusted core earnings per share for the year to 5.70 - 5.90 euros, down from 6.64 in 2017, short of analyst expectations, dragging the stock down as much as 3.7 percent in morning trade.

  • Reuters6 months ago

    EPA should revoke Monsanto weed killer approval, groups tell U.S. court

    The groups, which filed a lawsuit in February, want the court to force the EPA to vacate its approval of XtendiMax, arguing it not only harms nearby crops and plants but wildlife as well. It is not clear whether the court has the authority to revoke an EPA approval. The United States has faced a weed-killer crisis caused by the new formulations of dicamba-based herbicides, which farmers and weed experts say have harmed crops because they evaporate and drift away from where they are applied.

  • Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer
    Reuters6 months ago

    Exclusive: U.S. seed sellers push for limits on Monsanto, BASF weed killer

    Last summer, after farmers planted Monsanto's dicamba-resistant soy seeds en masse, the herbicide drifted onto nearby farms and damaged an estimated 3.6 million acres of non-resistant soybeans, or 4 percent of all U.S. plantings. The U.S. Environmental Protection Agency (EPA) is now weighing such complaints as part of a high-stakes decision on the herbicide's future. Bayer bought Monsanto and its portfolio of dicamba-resistant Xtend brand soy seeds for $63 billion this year in a deal that created the world's largest seed and pesticides maker.

  • Bayer says can begin integration of Monsanto
    Reuters6 months ago

    Bayer says can begin integration of Monsanto

    Bayer can begin folding Monsanto into its organisation as the antitrust-related sale of assets has been completed, fulfilling final requirements by the U.S. Department of Justice, the German drugmaker said on Thursday. "The integration of Monsanto into the Bayer Group can begin following the completion on Thursday of the divestment by Bayer to BASF of certain Crop Science businesses with a total sales volume of around 2.2 billion euros (£1.97 billion)," it said in a statement. Bayer already closed the deal, becoming the sole owner of Monsanto, on June 7 but had to hold off on the integration.

  • Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts
    Reuters6 months ago

    Monsanto Roundup appeal has uphill climb on 'junk science' grounds: legal experts

    Last week's verdict ended the first trial over whether glyphosate, the main ingredient in Roundup, causes cancer. Monsanto, which says decades of scientific studies have shown Roundup and glyphosate are safe, is facing about 5,000 similar lawsuits nationwide. Monsanto said on Monday it planned to challenge the verdict on the grounds that the judge should have barred scientific evidence presented by California school groundskeeper Dewayne Johnson's lawyers as insufficient.